Is MET or ALL a better buy right now?

Based on our latest analysis, MET is currently the stronger investment candidate based on our comprehensive scoring model.

Does MET or ALL have better growth?

Our analysis compares revenue and earnings growth. Check the 'Growth' section above to see which company is expanding faster. Typically, the stock with higher revenue growth rates is considered the better growth stock.

Which stock is cheaper: MET or ALL?

We compare P/E ratios and other valuation metrics in the 'Valuation' section. The stock with the lower P/E ratio is generally considered 'cheaper' relative to its earnings, though growth prospects must also be considered.

Which is the better buy right now, MET or ALL?

As of Nov 10, 2026, MET scores higher in our model: MET has an AI score of 57.7 versus 41.2 for ALL. MET is currently in a Markup technical phase and ALL is in a Neutral phase. Consider both scores and phases alongside your own risk tolerance.

What technical phase are MET and ALL in?

MET is in a Markup phase (Hold / add on dips) with an RSI of 56.7. ALL is in a Neutral phase (Hold) with an RSI of 55.6.

MET vs ALL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

MET

57.7

AI Score

MET Wins

ALL

41.2

AI Score

Investment Advisor Scores

MET

58score

Recommendation

HOLD

View Full Analysis

ALL

41score

Recommendation

HOLD

View Full Analysis

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric	MET	ALL	Winner
Revenue	58.75B	52.88B	MET
Net Income	4.32B	7.81B	ALL
Net Margin	7.3%	14.8%	ALL
ROE	19.4%	24.2%	ALL
ROA	0.6%	6.1%	ALL
Total Assets	744.61B	127.85B	MET
Cash	19.79B	549.00M	MET

Relative Price Performance (Last 90 Days)

MET 1M: +1.7% · 3M: +5.0% ALL 1M: +9.4% · 3M: -0.7%

Current Technical Phase

MET

Markup

Hold / add on dips

Price above SMA50, rising 50-day trend (1.8% over 20 days), RSI 57

RSI (14): 56.7 · Price: $102.32

ALL

Neutral

Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 55.6 · Price: $258.64

Fundamentals Snapshot

Metric	MET	ALL
Market Cap	—	—
Forward P/E	9.2	9.2
Trailing P/E	13.3	5.8
Revenue (TTM)	—	—
Revenue Growth	0.2%	0.0%
Gross Margin	0.3%	0.3%
Operating Margin	0.1%	0.2%
EPS	7.65	44.09
Dividend Yield	0.01%	0.02%

Frequently Asked Questions

Based on our detailed analysis, MET is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.

Related Analysis

MET

ALL

Data derived from SEC EDGAR filings and Tradestie proprietary analysis. Last updated: Nov 10, 2026 17:34 UTC. Refresh Data

Tradestie